These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Conduction System Abnormalities After Transcatheter Aortic Valve Replacement: Mechanism, Prediction, and Management. Judson GL; Agrawal H; Mahadevan VS Interv Cardiol Clin; 2019 Oct; 8(4):403-409. PubMed ID: 31445724 [TBL] [Abstract][Full Text] [Related]
29. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement. Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of membranous septum length in the prediction of major conduction disturbances in patients undergoing transcatheter aortic valve replacement with different devices. Aslan S; Demir AR; Çelik Ö; Kalkan AK; Uzun F; Güner A; Topel Ç; Ertürk M Kardiol Pol; 2020 Oct; 78(10):1020-1028. PubMed ID: 32735407 [TBL] [Abstract][Full Text] [Related]
31. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Nazif TM; Williams MR; Hahn RT; Kapadia S; Babaliaros V; Rodés-Cabau J; Szeto WY; Jilaihawi H; Fearon WF; Dvir D; Dewey TM; Makkar RR; Xu K; Dizon JM; Smith CR; Leon MB; Kodali SK Eur Heart J; 2014 Jun; 35(24):1599-607. PubMed ID: 24179072 [TBL] [Abstract][Full Text] [Related]
32. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK; JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819 [TBL] [Abstract][Full Text] [Related]
33. Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation. Laynez A; Ben-Dor I; Barbash IM; Hauville C; Sardi G; Maluenda G; Xue Z; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2012 Oct; 110(8):1164-8. PubMed ID: 22770935 [TBL] [Abstract][Full Text] [Related]
35. Transcatheter aortic valve replacement: relative safety and efficacy of the procedure with different devices. Del Val D; Ferreira-Neto AN; Asmarats L; Maes F; Guimaraes L; Junquera L; Wintzer J; Fischer Q; Barroso de Freitas Ferraz A; Puri R; Rodés-Cabau J Expert Rev Med Devices; 2019 Jan; 16(1):11-24. PubMed ID: 30526139 [TBL] [Abstract][Full Text] [Related]
36. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010 [TBL] [Abstract][Full Text] [Related]
37. Interventricular septal thickness on cardiac computed tomography as a novel risk factor for conduction disturbances in patients undergoing transcatheter aortic valve replacement. Schamroth Pravda N; Shaleve Y; Plakht Y; Shafir G; Grinberg T; Wiessman M; Aviv Y; Vaknin Assa H; Codner P; Golovchiner G; Barsheshet A; Kornowski R; Shiyovich A; Hamdan A Europace; 2024 May; 26(5):. PubMed ID: 38691562 [TBL] [Abstract][Full Text] [Related]
38. [New conduction disturbances and pacemaker indications after CoreValve® transcatheter aortic valve replacement. Incidence and follow up in a single center experience]. Aversa E; Muratore CA; Nemesio ML; Tentori MC; Payaslian M Arch Cardiol Mex; 2015; 85(4):278-83. PubMed ID: 25772651 [TBL] [Abstract][Full Text] [Related]
39. Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel. Rodés-Cabau J; Ellenbogen KA; Krahn AD; Latib A; Mack M; Mittal S; Muntané-Carol G; Nazif TM; Sondergaard L; Urena M; Windecker S; Philippon F J Am Coll Cardiol; 2019 Aug; 74(8):1086-1106. PubMed ID: 31439219 [TBL] [Abstract][Full Text] [Related]
40. Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve. Keßler M; Gonska B; Seeger J; Rottbauer W; Wöhrle J Am Heart J; 2017 Oct; 192():57-63. PubMed ID: 28938964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]